Safety and efficacy of bendamustine, lenalidomide and dexamethasone combination therapy in relapsed and refractory multiple myeloma
Latest Information Update: 07 Sep 2016
At a glance
- Drugs Bendamustine (Primary) ; Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 07 Sep 2016 New trial record